FIELD: medicine. SUBSTANCE: the present innovation deals with predicting infectious diseases. One should detect antibodies and specific immune complexes, moreover, in immunoenzymatic assay one should detect antibodies to nonstructural proteins (NS4) both in their free form and in composition of immune complexes, they should be washed parallel with buffer solution and 6M solution of urea followed by detecting the avidity of these antibodies. Acute form of hepatitis C is differentiated by the increase of antibodies' level by 12%, and chronic form by their decrease within 50-90%. EFFECT: higher efficiency and accuracy of diagnostics. 3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR ACUTE VIRAL HEPATITIS A IN CHILDREN | 2011 |
|
RU2479847C2 |
| METHOD OF DETERMINING AVIDITY OF IMMUNOGLOBULIN G TO HERPES VIRUS TYPE 6 | 2015 |
|
RU2596794C1 |
| SYNTHETIC OLIGOYPEPTIDES SPECIFICALLY INTERACTING WITH ANTIBODIES RAISED TO HEPATITIS C VIRUS, METHODS OF DIAGNOSIS HCV-INFECTION (VARIANTS) | 1994 |
|
RU2104284C1 |
| IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
| METHOD FOR MAKING LOW-TITRE SERUM PANEL FOR QUALITY CONTROL OF TEST SYSTEMS AND IMMUNOBLOTS USED FOR DIAGNOSING ANTIBODIES TO VARIOUS CVH SUBTYPES | 2009 |
|
RU2408024C1 |
| METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
| METHOD FOR PROGNOSIS OF ACUTE VIRAL HEPATITIS C FINISH | 2003 |
|
RU2269134C2 |
| METHOD FOR DETERMINING THE INFLUENCE OF LOW-MOLECULAR BIOLOGICALLY ACTIVE SUBSTANCES ON THE AFFINITE OF PROTEIN-LIGAND BONDING | 2018 |
|
RU2680408C1 |
| MONOCLONAL ANTIBODY IMMUNOREACTIVE WITH NUCLEOCAPSID (CORE) PROTEIN OF C-4G5 HEPATITIS VIRUS, METHOD OF DIAGNOSTICS OF HEPATITIS C VIRAL (HCV) INFECTION, AND COMBINATION OF MONOCLONAL ANTIBODIES FOR ITS IMPLEMENTATION | 2006 |
|
RU2329303C2 |
| ANTIGEN SET FOR SEPARATE DETECTION OF ANTIBODIES TO STRUCTURAL AND NON-STRUCTURAL PROTEINS OF HEPATITIS C VIRUS | 2007 |
|
RU2370776C2 |
